Opposition Continues to Materialize for Misdirected Patent Legislation

Two proposed patent bills, H.R. 3309, the “Innovation Act” – that was passed by the House last year, but has not yet been introduced in the Senate – and S. 1720, the “Patent Transparency and Improvements Act” – that has yet to come up for a vote in the Senate – both continue to face opposition from a broad cross section of organizations. These include:

  • Licensing Executives Society of the USA and Canada
  • Biotechnology Industry Organization
  • Federal Circuit Bar Association
  • American Intellectual Property Law Association
  • National Venture Capital Association
  • Patent Office Professional Association

Last December, David Kappos, the well respected former Director of the USPTO, wrote a compelling OpEd for The Hill. He has followed up that OpEd with an article in the San Jose Mercury News, the newspaper that serves the Silicon Valley, that he co-authored with Ben Pless, CEO of Autonomic Technologies. “Senate Legislation Would Seriously Damage Innovation Sector” details the many problems with S. 1720.

More evidence of the attempts by Big Tech to weaken U.S. Patents is available in a most comprehensive blog post by Gene Quinn at his IPWatchDog site.

American Innovators for Patent Reform (AIPR) continue to encourage its members to write, fax, e-mail or call their two U.S. Senators and express their opposition to H.R. 3309 and S. 1720. When you e-mail, we suggest you include a link to David Kappos’ and Ben Pless’s article in the Mercury News.